Details for New Drug Application (NDA): 212087
✉ Email this page to a colleague
The generic ingredient in MYCOPHENOLATE MOFETIL is mycophenolate mofetil hydrochloride. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mycophenolate mofetil hydrochloride profile page.
Summary for 212087
| Tradename: | MYCOPHENOLATE MOFETIL |
| Applicant: | Concord Biotech Ltd |
| Ingredient: | mycophenolate mofetil |
| Patents: | 0 |
Suppliers and Packaging for NDA: 212087
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MYCOPHENOLATE MOFETIL | mycophenolate mofetil | TABLET;ORAL | 212087 | ANDA | CONCORD BIOTECH LIMITED | 68254-5003 | 68254-5003-1 | 30 TABLET in 1 BOTTLE (68254-5003-1) |
| MYCOPHENOLATE MOFETIL | mycophenolate mofetil | TABLET;ORAL | 212087 | ANDA | CONCORD BIOTECH LIMITED | 68254-5003 | 68254-5003-2 | 100 TABLET in 1 BOTTLE (68254-5003-2) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Jul 31, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
